Apax Partners completes acquisition of Qualitest & Vintage Pharmaceuticals
5th November 2007
Apax Funds advised by Apax Partners have completed the acquisition of Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharma Funds advised by Apax Partners have completed the acquisition of Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharmaceuticals in the US.Huntsville, Alabama, USA, 05 November 2007 – Funds advised by Apax Partners (“Apax”) have completed the acquisition of Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharmaceuticals in the US. Signing of the transaction was initially announced in a press release issued on 17 September 2007.
Founded in 1983 by Mr. William S. Propst, Sr., Qualitest and Vintage Pharmaceuticals was established to provide quality generic pharmaceuticals at affordable prices. Today, the company produces tablets, capsules, liquids, suspensions, suppositories, creams, and ointments across a portfolio of over 160 products. The business has grown significantly over the past 24 years and is currently ranked among the top ten suppliers in the US of generic pharmaceuticals based on the total number of prescriptions filled.
NOTES TO EDITORS
About Apax Partners
Apax Partners is one of the world’s leading private equity investment groups. It operates across the United States, Europe and Asia and has more than 30 years of investing experience. Funds under the advice of Apax Partners total $20 billion around the world. These Funds provide long-term equity financing to build and strengthen world-class companies. Apax Partners Funds invest in companies across its global sectors of Tech & Telecom, Retail & Consumer, Media, Healthcare and Financial & Business Services.
For further information, please contact:
Ben Harding
Tel: +44 (0)20 7872 6401
Email: ben.harding@apax.com